anti-PD-1

Shares of Merck & Co., Inc. (NYSE: MRK) are rallying strongly, while Bristol-Myers Squibb Co (NYSE: BMY) is being punished on Wednesday. News Behind The Move The contrasting moves come after Merck announced late Tuesday that the FDA has accepted to review the sBLA for KEYTRUDA, plus...